The KEGG pathways mainly involved Alzheimer’s disease (hsa05010), neuroactive ligand-receptor interaction (hsa04080), calcium signaling pathway (sa04020), pathways in cancer (hsa05200), serotonergic synapse (hsa04726), and EGFR tyrosine kinase inhibitor resistance (hsa01521) (Figure 3a, Table S4). This evidence concerns the gene EGFR and Alzheimer disease.